Most monoclonal antibodies and vaccines target the spike protein of SARS-CoV-2. This protein is key to the pathogenicity of the

Vaccines formulated from adenoviral vectors, or mRNAs encoding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein, protect against